Home › Markets › Health Care › KAPA

Kairos Pharma Ltd. (KAPA)

KAPA trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.8287
-0.40% on the day
Market cap
$2.8M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerKAPA on NYSE
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryNot reported by the screener
IPO year2024
SEC CIK0001962011
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-04-01
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-08-12
Latest current report8-K2026-10-06
Latest proxyDEFA14A2026-05-26

Source: SEC EDGAR submissions feed, 123 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
HCWBHCW Biologics Inc.$1.26-14.87%$2.8M
MBIOMustang Bio Inc.$0.3768-8.63%$2.9M
PRFXPRF Technologies Ltd.$0.8180-4.88%$2.9M
ONCOOnconetix Inc.$0.5550-6.00%$2.9M
GOVXGeoVax Labs Inc.$0.2656-5.92%$2.7M
DCOYDecoy Therapeutics Inc.$1.24-13.29%$3.0M
XRTXXORTX Therapeutics Inc. Common Shares$1.68-2.33%$3.1M
APVOAptevo Therapeutics Inc.$1.73-5.79%$3.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier